Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
Primoris Services
PRIM
$4.39B
| $443K | ﹤0.01% |
17,869
-9,579
| -35% | -$251K |
|
|
EHIC
4302
DELISTED
eHi Car Services Limited
EHIC
| $443K | ﹤0.01% |
38,996
-139,804
| -78% | -$1.73M |
|
4303
CALL
BorgWarner
BWA
$14B
| $441K | ﹤0.01% |
11,701
-4,771
| -29% | -$187K |
|
|
XLNX
4304
PUT
DELISTED
Xilinx Inc
XLNX
| $441K | ﹤0.01% |
5,500
-6,100
| -53% | -$446K |
|
4305
Vanguard Information Technology ETF
VGT
$151B
| $440K | ﹤0.01% |
17,360
| – | – |
|
|
SLCT
4306
DELISTED
Select Bancorp, Inc.
SLCT
| $440K | ﹤0.01% |
35,554
+34,730
| +4,215% | +$450K |
|
4307
CALL
Ecolab
ECL
$78.1B
| $439K | ﹤0.01% |
2,800
-1,100
| -28% | -$163K |
|
4308
Evolus
EOLS
$536M
| $439K | ﹤0.01% |
23,630
+17,922
| +314% | +$388K |
|
|
SA
4309
CALL
Seabridge Gold
SA
$3.5B
| $438K | ﹤0.01% |
33,800
+500
| +2% | +$5.76K |
|
4310
First Citizens BancShares
FCNCA
$25.6B
| $437K | ﹤0.01% |
965
-8,702
| -90% | -$3.84M |
|
4311
PUT
KLA
KLAC
$274B
| $437K | ﹤0.01% |
43,000
+27,000
| +169% | +$295K |
|
4312
Natera
NTRA
$45.5B
| $437K | ﹤0.01% |
18,266
-1,062
| -5% | -$25.7K |
|
|
FBC
4313
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $437K | ﹤0.01% |
13,899
+8,758
| +170% | +$293K |
|
4314
PUT
Aptiv
APTV
$10.2B
| $436K | ﹤0.01% |
5,200
-4,500
| -46% | -$411K |
|
4315
CALL
Viking Therapeutics
VKTX
$3.84B
| $436K | ﹤0.01% |
+25,000
| New | +$298K |
|
4316
PUT
Nice
NICE
$6.17B
| $435K | ﹤0.01% |
3,800
+1,800
| +90% | +$201K |
|
|
SIVB
4317
CALL
DELISTED
SVB Financial Group
SIVB
| $435K | ﹤0.01% |
1,400
+500
| +56% | +$158K |
|
4318
CALL
Vanguard Morningstar Total Stock Market ETF
VTI
$696B
| $434K | ﹤0.01% |
2,900
-1,900
| -40% | -$280K |
|
4319
CGI
GIB
$15.3B
| $433K | ﹤0.01% |
6,722
-3,705
| -36% | -$241K |
|
4320
Hawkins
HWKN
$2.67B
| $432K | ﹤0.01% |
20,796
+13,814
| +198% | +$273K |
|
4321
TTEC Holdings
TTEC
$77.4M
| $432K | ﹤0.01% |
16,687
+8,793
| +111% | +$256K |
|
4322
Verastem
VSTM
$604M
| $432K | ﹤0.01% |
4,970
+4,647
| +1,439% | +$462K |
|
|
ACHN
4323
DELISTED
Achillion Pharmaceuticals
ACHN
| $432K | ﹤0.01% |
117,403
+65,874
| +128% | +$196K |
|
|
EBSB
4324
DELISTED
Meridian Bancorp, Inc.
EBSB
| $431K | ﹤0.01% |
25,346
+20,430
| +416% | +$373K |
|
4325
Invesco Preferred ETF
PGX
$3.77B
| $430K | ﹤0.01% |
30,000
| – | – |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.